Key result
Autoimmune disease linked to ~45% higher incident CVD risk in females, exceeding risk in males.
Why the study?
Autoimmune diseases are associated with increased CVD risk, and because immune responses, disease prevalence, and cardiovascular risk differ between females and males, this excess CVD risk may also vary by sex.
Does the excess risk of incident cardiovascular disease associated with autoimmune diseases differ between females and males in adults without prior cardiovascular disease?
Cohort (n=443,709)
Does the excess risk of incident cardiovascular disease associated with autoimmune diseases differ between females and males in adults without prior cardiovascular disease?
Autoimmune diseases confer a significantly higher relative risk of incident cardiovascular disease in females compared to males, with less of this excess risk in females explained by conventional cardiovascular risk factors.
Answers are grounded in this paper and cite their sources.
Supports heightened CV surveillance in patients with autoimmune disease, especially women; leaves open whether sex-specific preventive strategies improve outcomes.
Introduction Autoimmune diseases are associated with an increased risk of cardiovascular disease (CVD). Because immune responses, autoimmune disease prevalence, and cardiovascular risk differ substantially between females and males, excess risk of CVD associated with autoimmune diseases may also vary by sex. Aim We sought to examine sex differences in the magnitude and patterns of CVD risk associated with autoimmune diseases. Methods We used data from the UK Biobank, linked to secondary care records, to assemble a cohort without known CVD at enrolment. We identified 19 autoimmune diseases and cardiovascular risk factors at enrolment; missing data were imputed using multiple imputation by chained equations. Incident cases for 12 individual cardiovascular outcomes, as well as a composite cardiovascular outcome, were ascertained. We examined sex differences in the associations between autoimmune diseases and CVD using sex-stratified Cox proportional hazards models. We present estimates from age-adjusted models and from models additionally adjusted for known cardiovascular risk factors (socioeconomic status, smoking, body mass index, blood pressure, non-HDL cholesterol, diabetes, lipid-lowering and antihypertensive medication use, C-reactive protein, lipoprotein(a), and kidney function). Effect modification by sex was formally tested by including a sex interaction term in fully adjusted models. We quantified the proportion of excess risk attributable to measured risk factors in females and males as the relative log hazard ratio change between age-adjusted and fully adjusted models. Results Among 443,709 participants included in the study (56% females; mean [SD] age, 56.0 [8.1] years, 24,847 (5.6%) had at least one autoimmune disease at baseline; 15,158 (6.1%) amongst females. Over a median (IQR) follow-up of 13.6 (12.9-14.3) years, 6,621 participants (26.6%) with and 76,049 (18.2%) without autoimmune disease experienced incident CVD. Autoimmune disease was more strongly associated with incident CVD in females than males. In age-adjusted models for the composite outcome, hazard ratios were 1.63 (1.57-1.69) in females and 1.41 (1.36-1.46) in males; in fully adjusted models, 1.45 (1.40-1.50) in females and 1.25 (1.21-1.30) in males (Pinteraction<0.001). This pattern was observed across all individual outcomes, with the largest between-sex differences observed for peripheral artery disease, heart failure, and infective endocarditis (Figure). Adjustment for measured risk factors attenuated the autoimmune-associated hazard by 30%, with even a smaller attenuation in females (23.9%) than in males (34.4%). Conclusions Autoimmune diseases are associated with substantial excess risk for CVD in both sexes, which is only partially explained by known risk factors and varies by outcome. Females had a greater proportional increase in risk related to autoimmune diseases and a smaller proportion of risk explained by conventional factors.
No takes yet. Share an insight, caveat, or question.
Schuermans et al. (2026) conducted a cohort in Autoimmune diseases and cardiovascular disease (n=443,709). Autoimmune disease (19 types) vs. No autoimmune disease was evaluated on Composite incident cardiovascular disease (HR 1.45 in females; HR 1.25 in males (fully adjusted), 95% CI 1.40-1.50 (females); 1.21-1.30 (males), p=<0.001 for sex interaction). Autoimmune disease was more strongly associated with incident CVD in females than in males.
Synapse has enriched 10 related papers. Consider them for comparative context: